An ideal vaccine has to tick a lot of boxes – from efficacy and safety to being simple and cheap to make. Photo: AFP An ideal vaccine has to tick a lot of boxes – from efficacy and safety to being simple and cheap to make. Photo: AFP
An ideal vaccine has to tick a lot of boxes – from efficacy and safety to being simple and cheap to make. Photo: AFP

Coronavirus: vaccine pipeline bulges, but many won’t move out of the laboratory

  • After an unprecedented effort to develop them, the WHO says more than 81 candidates have entered or passed human trials
  • More than 350 million people have been immunised so far, however current vaccines are seen as works in progress

Topic |   Coronavirus pandemic
An ideal vaccine has to tick a lot of boxes – from efficacy and safety to being simple and cheap to make. Photo: AFP An ideal vaccine has to tick a lot of boxes – from efficacy and safety to being simple and cheap to make. Photo: AFP
An ideal vaccine has to tick a lot of boxes – from efficacy and safety to being simple and cheap to make. Photo: AFP
READ FULL ARTICLE